GIP and type 2 diabetes mellitus: Relief of extreme hyperglycemia (glucotoxicity) and enhanced secretion of the incretin hormone, glucose-dependent insulinotropic polypeptide, explained the improvement in pancreatic β-cell function in T2D subjects in their study.